Cargando…
Cost Effectiveness of Trastuzumab for Management of Breast Cancer in India
PURPOSE: We undertook this study to evaluate the incremental cost per quality-adjusted life-year (QALY) gained with use of adjuvant trastuzumab as compared with chemotherapy alone among patients with nonmetastatic breast cancer in India. METHODS: We used a Markov model to estimate the incremental co...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Clinical Oncology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051799/ https://www.ncbi.nlm.nih.gov/pubmed/32045547 http://dx.doi.org/10.1200/JGO.19.00293 |